Abstract
Background
Alpha and beta defensins have been isolated from various human tissues and form an important part of the innate immune system. Their role in implantation of the embryo has not yet been studied. This study was designed to detect both alpha and beta defensins in the mid luteal phase endometrium and investigate the correlation between the defensin expression and implantation of the embryo.
Method and results
An experimental study was designed to detect α defensin (HNP1–3) and β defensin (HBD1) in midluteal phase endometrial samples obtained from women attending the IVF unit at the Liverpool Women’s Hospital, UK. Samples were obtained at least two menstrual cycles before IVF treatment was commenced. Immunohistochemical staining was conducted to estimate defensin expression. Some endometrial stromal cells stained positive for HNP1–3 during the midluteal phase. HNP1–3 expression is significantly higher in cases presenting with female factor infertility as compared with purely male factor infertility. A significant increase was not observed in tubal factor or endometriosis when considered separately. Endometrial stromal neutrophils were shown to be the main source of endomatrial HNP1–3. HBD1 was the only beta defensin detected by immunochemical staining in the midluteal phase endometrium. The intensity of staining was significantly different in the endometrial stroma, luminal and glandular epithelia. HBD1 expression is not significantly higher in female factor infertility.
Conclusion
The study confirmed secretion of HNP1–3 by endometrial stromal neutrophils. Glandular epithelium is the main source of HBD1 expression in the human endometrium. HNP1–3 shows increased expression in female factor infertility. HBD1 expression is not higher in female factor infertility. These defensins do not appear to influence implantation.
Similar content being viewed by others
References
Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427–35.
Hoffman JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313–8.
Schroder JM, Harder J. Human beta-defensin 2. Int J Biochem Cell Biol. 1999;31:645–51.
Lehrer A, Lichtenstein A, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Anuual Rev Immunol. 1993;11:105–28.
Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynaecol. 1997;176:470–5.
Quayle AJ, Porter EM, Nussbaum AA. Gene expression, immunolocalisation and secretion of human defensin-5 in human female reproductive tract. Am J Path. 1998;152(5):1247–58.
Bensch KW, Raida M, Magert HJ, Schultz-Knappe P, Forssmann WG. HBD 1: a novel beta-defensin from human plasma. FEBS Lett. 1995;368:331–5.
Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, et al. HBD 2 is a salt sensitive peptide antibiotic expressed in human lung. J Clin Invest. 1998;102:874–80.
Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterisation of human beta-defensin 3, a novel human inducible peptide abtibiotic. J Biol Chem. 2001;275:5707–13.
Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez J, Kluver E, Adermann K, et al. Human beta-defensin 4: a novel human inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. Faseb J. 2001;15:1819–21.
King AE, Fleming DC, Critchley HOD, Kelly RW. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod. 2002;8:341–9.
King AE, Fleming DC, Critchley HOD, Kelly RW. Differential expression of natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol. 2003a;59:1–16.
Fleming DC, King AE, Williams ARW, Critchley HOD, Kelly RW. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril. 2003;79(4):856–63.
Bergh PA, Navot D. the impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril. 1992;58:537–42.
Murphy CR. The cytoskeleton of uterine epithelial cells: a new player in uterine receptivity and plasma membrane transformation. Hum Reprod Update. 1995;6:567–80.
Krisanaprakornit S, Weinberg A, Perez CN, Dale BA. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun. 1998;66:4222–8.
Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin HBD-1 in human secretory glands and epithelial cells. FEBS Lett. 1996;396:319–22.
O’Neil DA, Porter E, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. Expression and regulation of defensins HBD-1 and HBD-2 in intestinal epithelium. J Immunol. 1999;163:6718–24.
Bulmer JN, Longfellow M, Ritson A. Leucocytes and resident blood cells in endometrium. Ann N Y Acad Sci. 1991;622:57–68.
King A, Loke YW. On the nature and function of human granular lymphocytes. Immunol Today. 1995;12:432–5.
King AE, Critchley HOD, Kelly RW. Innate immune defences in the human endometrium. Reprod Biol and Endocrinol. 2003b;1:116.
Agerbeth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lmphocyte and monocyte populations. Blood. 2000;96:3086–93.
Mason DY. Immunocytochemical labelling of monoclonal antibodies by the APAAP immunoalkaline phopsphatase technique. In: Bullock GR, Petrusz P, editors. New York: Academic Press; 1985. pp. 25–42.
Ryley HC. Human antimicrobial peptides. Rev Med Microbiol. 2001;12(3):177–88.
Heine RP, Weisenfeld H, Mortimer L, Greig PC. Amniotic fluid defensins: potential markers of subclinical intrauterine infection. Clin Infect Dis. 1998;27:513–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Das, S., Vince, G.S., Lewis-Jones, I. et al. The expression of human alpha and beta defensin in the endometrium and their effect on implantation. J Assist Reprod Genet 24, 533–539 (2007). https://doi.org/10.1007/s10815-007-9173-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-007-9173-2